In glioblastoma harboring PI3K/mTOR activation due to PTEN deficiency, combined inhibition using the SMO inhibitor LDE225 and the PI3K inhibitor BKM120 was necessary to reduce cell viability and inhibit tumor growth [12]. The gene discussed is MTOR; the disease is neoplasm.